Full Year 2017 Hikma Pharmaceuticals PLC Earnings Call

14/3/2018 5:30

Conference Call Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC Conference call or earnings call will be held on 14-Mar-2018
During the earnings conference call’s session, Hikma Pharmaceuticals PLC will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact Hikma Pharmaceuticals PLC for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company develops, manufactures and markets a range of branded and non-branded generic pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms, across the United States, the Middle East and North Africa (MENA) region and Europe. The Company's segments include Branded, Injectables, Generics and Others. The Branded business sells branded generics and in-licensed products across the MENA region and other markets. The Injectables business sells specialized generic injectable products across the globe. The Generics business sells non-injectable generic products in the United States. The Branded business has approximately 380 products in over 1,120 dosage forms and strengths. Its products include Amoclan, Blopress, Omnicef, Prograf and Suprax. The Injectables business' products include Argatroban, Fentanyl, Glycopyrrolate, Nicardipine and Phenylephrine.
Read more Conference Call

Hikma Pharmaceuticals PLC (HIK.L)

Hikma Pharmaceuticals PLC 13 Hanover Square LONDON     W1S 1HL P: +4420.73992760 F: +4420.73992761